Contact

All Stories

  1. Interpreting the functional impact of genetic variants: The need for context qualifiers

    Article • The American Journal of Human Genetics, December 2025, Elsevier

    Dr. Dmitriy Sonkin

  2. Cancer treatments: Past, present, and future

    Article • Cancer Genetics, August 2024, Elsevier

    Dr. Dmitriy Sonkin

  3. Improving transparency of computational tools for variant effect prediction

    Article • Nature Genetics, July 2024, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  4. Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource

    Article • Molecular Cancer Therapeutics, August 2023, American Association for Cancer Research (AACR)

    Dr. Dmitriy Sonkin

  5. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

    Article • Genetics in Medicine, May 2022, Elsevier

    Dr. Dmitriy Sonkin

  6. TP53 isoform junction reads based analysis in malignant and normal contexts

    Article • Scientific Reports, August 2021, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  7. MutSpliceDB: A database of splice sites variants with RNA‐seq based evidence on effects on splicing

    Article • Human Mutation, March 2021, Wiley

    Dr. Dmitriy Sonkin

  8. Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets

    Article • Clinical Epigenetics, June 2020, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  9. A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

    Article • Nature Genetics, April 2020, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  10. Standard operating procedure for curation and clinical interpretation of variants in cancer

    Article • Genome Medicine, November 2019, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  11. Early Detection is as Important as Imatinib in CML Treatment Success

    Article • October 2019, MDPI AG

    Dr. Dmitriy Sonkin

  12. Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?

    Article • Lung Cancer Management, October 2019, Future Medicine

    Dr. Dmitriy Sonkin

  13. Bioinformatics Tools and Resources for Cancer Immunotherapy Study

    Article • September 2019, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  14. Next-generation characterization of the Cancer Cell Line Encyclopedia

    Article • Nature, May 2019, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  15. Neuroendocrine negative SCLC is mostly RB1 WT and may be sensitive to CDK4/6 inhibition: Supplemental Tables

    Article • January 2019, Cold Spring Harbor Laboratory Press

    Dr. Dmitriy Sonkin

  16. Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community‐driven standards

    Article • Human Mutation, October 2018, Wiley

    Dr. Dmitriy Sonkin

  17. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes

    Article • Human Mutation, October 2018, Wiley

    Dr. Dmitriy Sonkin

  18. ClinGen Cancer Somatic Working Group – standardizing and democratizing access to cancer molecular diagnostic data to drive translational research

    Article • November 2017, World Scientific Pub Co Pte Lt

    Dr. Dmitriy Sonkin

  19. Detection of homozygous deletions in tumor-suppressor genes ranging from dozen to hundreds nucleotides in cancer models

    Article • Human Mutation, August 2017, Wiley

    Dr. Dmitriy Sonkin

  20. Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent

    Article • Cancer Medicine, August 2017, Wiley

    Dr. Dmitriy Sonkin

  21. Somatic cancer variant curation and harmonization through consensus minimum variant level data

    Article • Genome Medicine, November 2016, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  22. TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

    Article • Human Mutation, July 2016, Wiley

    Dr. Dmitriy Sonkin

  23. Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression

    Article • JNCI Journal of the National Cancer Institute, May 2016, Oxford University Press (OUP)

    Dr. Dmitriy Sonkin

  24. Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity

    Article • BMC Systems Biology, February 2016, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  25. Pharmacogenomic agreement between two cancer cell line data sets

    Article • Nature, November 2015, Nature

    Professor Julio Saez-Rodriguez, Dr. Dmitriy Sonkin

  26. Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors

    Article • eLife, October 2015, eLife

    Dr. Dmitriy Sonkin

  27. The identification and characterization of a STAT5 gene signature in hematologic malignancies

    Article • Cancer Biomarkers, January 2015, IOS Press

    Dr. Dmitriy Sonkin

  28. Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling

    Article • Cancer Research, April 2014, American Association for Cancer Research (AACR)

    Dr. Dmitriy Sonkin

  29. Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer

    Article • Cancer Research, August 2013, American Association for Cancer Research (AACR)

    Dr. Dmitriy Sonkin

  30. Tumor Suppressors Status in Cancer Cell Line Encyclopedia

    Article • Molecular Oncology, April 2013, Wiley

    Dr. Dmitriy Sonkin

  31. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Article • Nature, March 2012, Springer Science + Business Media

    Dr. Dmitriy Sonkin

  32. Maintenance of adenomatous polyposis coli ( APC )-mutant colorectal cancer is dependent on Wnt/β-catenin signaling

    Article • Proceedings of the National Academy of Sciences, September 2011, Proceedings of the National Academy of Sciences

    Dr. Dmitriy Sonkin

  33. Genetic Mechanisms in Apc-Mediated Mammary Tumorigenesis

    Article • PLoS Genetics, February 2009, PLOS

    Dr. Dmitriy Sonkin

  34. Loss of Rb1 in the gastrointestinal tract of Apc 1638N mice promotes tumors of the cecum and proximal colon

    Article • Proceedings of the National Academy of Sciences, October 2008, Proceedings of the National Academy of Sciences

    Dr. Dmitriy Sonkin